Mineralocorticoid receptor antagonists reduce inflammatory signaling independent of myofiber mineralocorticoid receptor

Chronic inflammation is a feature of Duchenne muscular dystrophy (DMD), a degenerative striated muscle disease. Mineralocorticoid receptor (MR) antagonists (MRAs) have demonstrated clinical benefit on later onset DMD cardiomyopathy, and preclinical studies in mouse models have demonstrated efficacy...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Jeovanna Lowe, Arden B. Piepho, Chetan K. Gomatam, Peyton Debell, Megan N. Ballinger, Jill A. Rafael-Fortney
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2025-12-01
Schriftenreihe:	Endocrine and Metabolic Science
Schlagworte:	Inflammation Muscular dystrophy mdx Mineralocorticoid receptor Myeloid
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2666396125000524
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!